These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Relation of response to treatment with dorzolamide in X-linked retinoschisis to the mechanism of functional loss in retinoschisin. Walia S; Fishman GA; Molday RS; Dyka FM; Kumar NM; Ehlinger MA; Stone EM Am J Ophthalmol; 2009 Jan; 147(1):111-115.e1. PubMed ID: 18834580 [TBL] [Abstract][Full Text] [Related]
5. Use of topical dorzolamide for patients with X-linked juvenile retinoschisis: case report. Bastos AL; Freitas Bde P; Villas Boas O; Ramiro AC Arq Bras Oftalmol; 2008; 71(2):286-90. PubMed ID: 18516436 [TBL] [Abstract][Full Text] [Related]
6. Effect of light and diurnal variation on macular thickness in X-linked retinoschisis: a case series. Rubinstein Y; Weiner C; Chetrit N; Newman H; Hecht I; Shoshany N; Pras E Graefes Arch Clin Exp Ophthalmol; 2020 Mar; 258(3):529-536. PubMed ID: 31897705 [TBL] [Abstract][Full Text] [Related]
7. Clinical findings and Chen C; Xie Y; Sun T; Tian L; Xu K; Zhang X; Li Y Mol Vis; 2020; 26():291-298. PubMed ID: 32300273 [TBL] [Abstract][Full Text] [Related]
8. POSSIBLE EFFICACY OF TOPICAL DORZOLAMIDE IN THE TREATMENT OF PACLITAXEL-RELATED CYSTOID MACULAR EDEMA. Dwivedi R; Tiroumal S Retin Cases Brief Rep; 2018 Winter; 12(1):75-79. PubMed ID: 27749791 [TBL] [Abstract][Full Text] [Related]
9. Dramatic response to topical dorzolamide in X-linked retinoschisis. Thangavel R; Surve A; Azad S; Kumar V Indian J Ophthalmol; 2020 Jul; 68(7):1466-1467. PubMed ID: 32587200 [TBL] [Abstract][Full Text] [Related]
10. Clinical and Genetic Study of X-Linked Juvenile Retinoschisis in the Czech Population. Kousal B; Hlavata L; Vlaskova H; Dvorakova L; Brichova M; Dubska Z; Langrova H; Vincent AL; Dudakova L; Liskova P Genes (Basel); 2021 Nov; 12(11):. PubMed ID: 34828422 [TBL] [Abstract][Full Text] [Related]
11. Use of dorzolamide for patients with X-linked retinoschisis. Apushkin MA; Fishman GA Retina; 2006 Sep; 26(7):741-5. PubMed ID: 16963845 [TBL] [Abstract][Full Text] [Related]
12. EFFICACY OF ADJUVANT TOPICAL DORZOLAMIDE-TIMOLOL IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION REFRACTORY TO ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY. Lee JH; Lee SC; Byeon SH; Koh HJ; Kim SS; Lee CS Retina; 2019 Oct; 39(10):1953-1958. PubMed ID: 30161096 [TBL] [Abstract][Full Text] [Related]
13. A combination of topical and systemic carbonic anhydrase in the treatment of chromosome X-linked retinoschisis. Rocha Cabrera P; Pareja Ríos AC; Cordovés Dorta L; Mantolán Sarmiento C; Serrano García MA Arch Soc Esp Oftalmol; 2014 Aug; 89(8):320-3. PubMed ID: 24269421 [TBL] [Abstract][Full Text] [Related]
14. Phenotypic Characteristics of a French Cohort of Patients with X-Linked Retinoschisis. Orès R; Mohand-Said S; Dhaenens CM; Antonio A; Zeitz C; Augstburger E; Andrieu C; Sahel JA; Audo I Ophthalmology; 2018 Oct; 125(10):1587-1596. PubMed ID: 29739629 [TBL] [Abstract][Full Text] [Related]